Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Chromadex Corp (CDXC)

  • Technical Exchange News
  • March 19, 2025, 00:16 UTC
  • 32
  • 0 comments

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: ChromaDex Corporation - Common Stock.

Comment Full text

AlloVir Inc (ALVR)

  • Technical Exchange News
  • March 19, 2025, 00:16 UTC
  • 32
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: AlloVir, Inc. - Common Stock.

Comment Full text

Chromadex Corp (CDXC)

  • Technical Exchange News
  • March 19, 2025, 00:16 UTC
  • 28
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: ChromaDex Corporation - Common Stock.

Comment Full text

Avenue Therapeutics Inc (ATXI)

  • Technical Exchange News
  • March 18, 2025, 19:07 UTC
  • 34
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Minerva Neurosciences Inc (NERV)

  • Technical Exchange News
  • March 18, 2025, 02:00 UTC
  • 34
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Inspira Technologies Oxy BHN (IINN)

  • Technical Exchange News
  • March 18, 2025, 02:00 UTC
  • 34
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Minerva Neurosciences Inc (NERV)

  • Technical Exchange News
  • March 17, 2025, 19:04 UTC
  • 34
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Inspira Technologies Oxy BHN (IINN)

  • Technical Exchange News
  • March 17, 2025, 19:03 UTC
  • 34
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Tiziana Life Sciences Ltd. (TLSA)

  • Technical Exchange News
  • March 15, 2025, 01:45 UTC
  • 39
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Tiziana Life Sciences Ltd. (TLSA)

  • Technical Exchange News
  • March 14, 2025, 19:32 UTC
  • 33
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text
  • Previous
  • 173
  • 174
  • 175
  • 176
  • 177
  • Next

Search

News categories

  • Technical Exchange News(10333)
  • Event(1541)
  • SEC News(176744)
  • FDA Approval(9672)
  • Company Report(721)
  • Business News(118365)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin